DE60108272D1 - Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol - Google Patents

Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol

Info

Publication number
DE60108272D1
DE60108272D1 DE60108272T DE60108272T DE60108272D1 DE 60108272 D1 DE60108272 D1 DE 60108272D1 DE 60108272 T DE60108272 T DE 60108272T DE 60108272 T DE60108272 T DE 60108272T DE 60108272 D1 DE60108272 D1 DE 60108272D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
secoisolaricinesinol
composition containing
secoisolariciresinol
antioxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60108272T
Other languages
English (en)
Other versions
DE60108272T2 (de
Inventor
Madhusudana Rao
Kumar Tiwari
Sampath Kumar
Singh Yadav
Vijaya Raghavan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Application granted granted Critical
Publication of DE60108272D1 publication Critical patent/DE60108272D1/de
Publication of DE60108272T2 publication Critical patent/DE60108272T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/34—Separation; Purification; Stabilisation; Use of additives
    • C07C41/36—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/34—Separation; Purification; Stabilisation; Use of additives
    • C07C41/38—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60108272T 2001-07-27 2001-08-20 Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol Expired - Lifetime DE60108272T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US917607 2001-07-27
US09/917,607 US6489514B1 (en) 2001-07-27 2001-07-27 (-)-Secoisolariciresinol as an antioxidant obtained from a new natural source namely stereospermum personatum
PCT/IN2001/000146 WO2003020254A1 (en) 2001-07-27 2001-08-20 Pharmaceutical composition comprising (-)-secoisolariciresinol

Publications (2)

Publication Number Publication Date
DE60108272D1 true DE60108272D1 (de) 2005-02-10
DE60108272T2 DE60108272T2 (de) 2005-06-23

Family

ID=25439045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60108272T Expired - Lifetime DE60108272T2 (de) 2001-07-27 2001-08-20 Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol

Country Status (8)

Country Link
US (1) US6489514B1 (de)
EP (1) EP1411909B1 (de)
JP (1) JP2005501886A (de)
KR (1) KR100809731B1 (de)
CN (1) CN1329026C (de)
CA (1) CA2454786C (de)
DE (1) DE60108272T2 (de)
WO (1) WO2003020254A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100639273B1 (ko) * 2002-07-24 2006-10-31 가부시끼가이샤 고또스기 홍두삼 유래 리그난류를 포함하는 혈당 강하제
FR2851919A1 (fr) * 2003-03-03 2004-09-10 Lmd Lignanes utilisables comme inhibiteurs de cathepsines et leurs applications
DE10354380A1 (de) * 2003-11-20 2005-06-16 Basf Ag Verwendung von Lignanen in kosmetischen oder dermatologischen Zubereitungen
RU2359666C2 (ru) * 2007-03-29 2009-06-27 Николай Эдуардович Нифантьев Способ выделения секоизоларицирезинола и дигидрокверцетина из древесины (варианты)
CN104434900B (zh) * 2014-11-10 2017-07-14 中国人民解放军第二军医大学 Lca在制备治疗关节炎症或关节软骨及骨质破坏的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473620A (en) * 1982-12-23 1984-09-25 Eastman Kodak Company Encapsulated butylated hydroxyanisole
US5837256A (en) * 1995-12-21 1998-11-17 Clark; William F. Method for treatment of Lupus nephritis
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
CA2312164C (en) * 1999-06-30 2009-12-15 University Of Saskatchewan Technologies Inc. Antioxidant activity in sdg metabolites

Also Published As

Publication number Publication date
CN1329026C (zh) 2007-08-01
KR100809731B1 (ko) 2008-03-06
DE60108272T2 (de) 2005-06-23
EP1411909A1 (de) 2004-04-28
WO2003020254A1 (en) 2003-03-13
KR20040019365A (ko) 2004-03-05
CA2454786C (en) 2010-09-14
EP1411909B1 (de) 2005-01-05
CN1536990A (zh) 2004-10-13
US6489514B1 (en) 2002-12-03
JP2005501886A (ja) 2005-01-20
WO2003020254A8 (en) 2003-05-08
CA2454786A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
ATE433447T1 (de) Pyrimiidinverbindungen
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
MA29627B1 (fr) Modifications cristallines de la pyraclostrobine
EA200800415A1 (ru) Удаление пероксида из носителя для доставки лекарственного средства
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
SE0301010D0 (sv) Novel compounds
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
NO20050741L (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
SE0301009D0 (sv) Novel compounds
CL2004000969A1 (es) Compuestos derivados de alquilarilo; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o profilaxis de la obesidad y trastornos relacionados.
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
MXPA05012837A (es) Inhibidores de caspasa y usos de los mismos.
SE0302139D0 (sv) Novel compounds
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
BR0208813A (pt) Composições contendo imidazotriazinona para a aplicação nasal
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
ATE443044T1 (de) Tace inhibitoren
SE0303280D0 (sv) Novel compounds
DE60108272D1 (de) Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
MXPA03008801A (es) Aril oxima-piperazinas utiles como antagonistas de ccr5.
DE60201074D1 (en) Pyrazolopyridinderivate
ATE393624T1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition